You have 9 free searches left this month | for more free features.

City

Melbourne (1)

Shanghai (1)

Condition

Advanced Solid Tumor (1)

Biliary Tract Cancer (1)

Candonilimab (1)

Claudin 18.2 (1)

Overall Status

Enrolling by invitation (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

LaNova Australia Pty Limited (1)

Shanghai Zhongshan Hospital (1)

Collaborator

Intervention

lm-302 (2)

cardonilizumab (1)

toripalimab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

lm-302

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Biliary Tract Cancer, Candonilimab, Claudin 18.2 Trial in Shanghai (cardonilizumab, LM-302)

Recruiting

Biliary Tract Cancer
+2 more

cardonilizumab
LM-302

Shanghai, China

Zhongshan hospital, Fudan University

Aug 12, 2023

Advanced Solid Tumor Trial in Melbourne (LM-302, Toripalimab)

Enrolling by invitation

Advanced Solid Tumor

LM-302
Toripalimab

Melbourne, Australia

The Alfred

May 20, 2022